DE69532198T2 - Antitumor-indolopyrolocarbazolderivat - Google Patents

Antitumor-indolopyrolocarbazolderivat Download PDF

Info

Publication number
DE69532198T2
DE69532198T2 DE69532198T DE69532198T DE69532198T2 DE 69532198 T2 DE69532198 T2 DE 69532198T2 DE 69532198 T DE69532198 T DE 69532198T DE 69532198 T DE69532198 T DE 69532198T DE 69532198 T2 DE69532198 T2 DE 69532198T2
Authority
DE
Germany
Prior art keywords
compound
formula
present
group
same meanings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69532198T
Other languages
German (de)
English (en)
Other versions
DE69532198D1 (de
Inventor
Katsuhisa Kojiri
Hisao Kondo
Hiroharu Arakawa
Mitsuru Ohkubo
Hiroyuki Suda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Priority claimed from PCT/JP1995/000868 external-priority patent/WO1995030682A1/ja
Publication of DE69532198D1 publication Critical patent/DE69532198D1/de
Application granted granted Critical
Publication of DE69532198T2 publication Critical patent/DE69532198T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • C07C243/16—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DE69532198T 1994-05-09 1995-05-02 Antitumor-indolopyrolocarbazolderivat Expired - Fee Related DE69532198T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP11948394 1994-05-09
JP11948394 1994-05-09
JP14564894 1994-06-03
JP14564894 1994-06-03
PCT/JP1995/000868 WO1995030682A1 (en) 1994-05-09 1995-05-02 Antitumor indolopyprolocarbazole derivative

Publications (2)

Publication Number Publication Date
DE69532198D1 DE69532198D1 (de) 2004-01-08
DE69532198T2 true DE69532198T2 (de) 2004-08-26

Family

ID=26457215

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69532198T Expired - Fee Related DE69532198T2 (de) 1994-05-09 1995-05-02 Antitumor-indolopyrolocarbazolderivat
DE69533833T Expired - Fee Related DE69533833T2 (de) 1994-05-09 1995-05-02 Verfahren zur Herstellung von Indolopyrrolocarbazol-Derivaten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69533833T Expired - Fee Related DE69533833T2 (de) 1994-05-09 1995-05-02 Verfahren zur Herstellung von Indolopyrrolocarbazol-Derivaten

Country Status (14)

Country Link
EP (2) EP0760375B1 (enExample)
JP (1) JP3038921B2 (enExample)
KR (1) KR100312473B1 (enExample)
CN (2) CN1106400C (enExample)
AT (2) ATE255121T1 (enExample)
AU (1) AU683749B2 (enExample)
CA (1) CA2190007C (enExample)
CL (1) CL2004001117A1 (enExample)
DE (2) DE69532198T2 (enExample)
DK (2) DK0760375T3 (enExample)
ES (2) ES2230433T3 (enExample)
HK (1) HK1000890A1 (enExample)
PT (2) PT1264836E (enExample)
TW (1) TW313566B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1541582A1 (en) * 2002-08-23 2005-06-15 Banyu Pharmaceutical Co., Ltd. Process for producing indolopyrrolocarbazole derivative
CN101585861B (zh) * 2009-07-03 2012-10-24 复旦大学 N-糖基萘并咔唑化合物及其合成方法和应用
WO2025082431A1 (zh) * 2023-10-18 2025-04-24 正大天晴药业集团股份有限公司 一种吲哚衍生物治疗头颈部肿瘤的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
EP0528030B1 (en) * 1990-05-11 1997-09-17 Banyu Pharmaceutical Co., Ltd. Antitumor be-13793c derivative
NZ245203A (en) 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
WO1995034663A1 (en) * 1994-06-13 1995-12-21 Banyu Pharmaceutical Co., Ltd. Gene coding for glycosyltransferase and use thereof
AU3086495A (en) * 1994-08-02 1996-03-04 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazoles

Also Published As

Publication number Publication date
DK0760375T3 (da) 2003-12-29
PT760375E (pt) 2004-04-30
ATE255121T1 (de) 2003-12-15
CN1106400C (zh) 2003-04-23
HK1000890A1 (en) 2004-01-09
ES2206501T3 (es) 2004-05-16
PT1264836E (pt) 2005-02-28
CA2190007A1 (en) 1995-11-16
CL2004001117A1 (es) 2005-04-22
EP1264836A1 (en) 2002-12-11
ES2230433T3 (es) 2005-05-01
CA2190007C (en) 2003-04-15
DE69533833T2 (de) 2005-12-15
DE69532198D1 (de) 2004-01-08
JP3038921B2 (ja) 2000-05-08
EP0760375A4 (en) 2002-03-27
CN1285605C (zh) 2006-11-22
KR970702869A (ko) 1997-06-10
CN1153518A (zh) 1997-07-02
AU683749B2 (en) 1997-11-20
DK1264836T3 (da) 2005-03-07
CN1513865A (zh) 2004-07-21
ATE283863T1 (de) 2004-12-15
EP0760375B1 (en) 2003-11-26
DE69533833D1 (de) 2005-01-05
TW313566B (enExample) 1997-08-21
HK1067948A1 (en) 2005-04-22
KR100312473B1 (ko) 2002-06-24
EP1264836B1 (en) 2004-12-01
AU2353595A (en) 1995-11-29
EP0760375A1 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
DE69617273T2 (de) Heterocyclisch substituierte cyclopentanderivate.
DE3783577T2 (de) Rebeccamycin-analoge verbindungen.
EP0286028B1 (de) Desaza-purin-nucleosid-Derivate, Verfahren zu deren Herstellung sowie deren Verwendung bei der Nucleinsäure-Sequenzierung sowie als antivirale Mittel
EP0642513B1 (de) Indolocarbazol-imide und deren verwendung
DE69206242T2 (de) Indolopyrrolocarbazolederivate.
DD282686A5 (de) Verfahren zur herstellung eines benzothiazolderivates
EP1280771A2 (de) Neue prodrugs von 6-hydroxy-2,3-dihydro-1h-indolen, 5-hydroxy-1,2-dihydro-3h-pyrrolo 3,2-e]indolen und 5-hydroxy-1,2-dihydro-3h-benzo e]indolen sowie von 6-hydroxy-1,2,3,4-tetrahydro-benzo f]chinolin-derivaten für eine selektive krebstherapie
DE3044740C2 (enExample)
DE3942296A1 (de) Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung
US5922860A (en) Antitumor indolopyrrolocarbazole derivatives
DE69127691T2 (de) Be-13793c-derivat mit antitumorwirkung
US5804564A (en) Antitumor indolopyrrolocarbazole derivatives
AT392793B (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
DE3940021C2 (de) Adenosin-Derivate, deren Herstellung und Verwendung
EP0304086B1 (en) 4'-deshydroxyepipodophyllotoxin glucosides and their use
CH665641A5 (de) Acylamino-mitosane.
DE2917000C2 (de) 1β-(6-Amino-9H-purin-9-yl)-4-hydroxymethyl-4-cyclopenten-2α,3α-diol (Neplanocin A), Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
DE69819340T2 (de) Optisch reine camptothecinanaloge, optisch reines synthese-zwischenprodukt und verfahren zu ihrer herstellung
NZ225089A (en) 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives and pharmaceutical compositions
AT390618B (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
DE68928127T2 (de) 2'-Methylidenpyrimidinnukleosidverbindungen, ihre Verwendung und Verfahren zu ihrer Herstellung
EP0760375B1 (en) Antitumor indolopyprolocarbazole derivative
CH660740A5 (de) Halogenanthracyclinglykoside.
DE69719071T2 (de) Phenanthridiniumderivate
EP0180833B1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee